Justine talks about union blockades, annual leave and what benefits joining a union can bring for people from all employment types. Whakarongo mai nei!
On a very health-focused Wire for Rāapa Wednesday.
News and Editorial Director Jessica Hopkins spoke to NZ Drug Foundation Principal Science Advisor, Emily Hughes, about synthetic opioids being sold as other substances.
She also spoke to Association of Salaried Medical Specialists Executive Director, Sarah Dalton, about how the incoming governments proposed tax cuts could impact investment in the health sector.
And she spoke to senior research fellow at the University of Otago, Dr Julie Bennett, about World Ventil8 Day.
Arno spoke to Assistant National Secretary of the Public Services Association, Melissa Woolley, and care and support worker, Monique Behan-Kitto, about their pay equity settlement that has been delayed by Te Whatu Ora.
And he spoke to Bioengineer at the University of Auckland Dr Kelly Burrowes about new research on how vaping affects the lungs.
Drug checking providers have reported seeing an increase in a group of synthetic opioids, nitazines, being sold as other substances, with the High Alert warning this week about a highly potent synthetic opioid being misrepresented as butonitazene.
News and Editorial Director Jessica Hopkins spoke to NZ Drug Foundation Principal Science Advisor Emily Hughes about this recent development.
She started off the interview asking Hughes why they are concerned about the growing prevalence of nitazenes in the community, especially if they are being sold as something else.